跳转至内容
Merck
CN

MABS65

抗胰岛素受体抗体(β亚基,克隆CT-3)

clone CT-3, from mouse

别名:

CD220 antigen, insulin receptor

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗胰岛素受体抗体(β亚基,克隆CT-3), clone CT-3, from mouse

biological source

mouse

conjugate

unconjugated

antibody form

purified antibody

antibody product type

primary antibodies

clone

CT-3, monoclonal

species reactivity

mouse, rat (demonstrated by independent lab), human

technique(s)

immunohistochemistry: suitable
western blot: suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Quality Level

Gene Information

human ... INSR(3643)
mouse ... Insr(16337)
rat ... Insr(24954)

Analysis Note

对照
小鼠脑组织裂解液
通过蛋白质印迹法在小鼠脑组织裂解物中进行评价。

蛋白质印迹分析:0.5 µg/mL 的该抗体在 10 µg 小鼠脑组织裂解物中检测到胰岛素受体β亚基。

Application

使用该经验证可用于WB、IH的该抗胰岛素受体抗体(β亚基,克隆CT-3)检测胰岛素受体。
研究子类别
胰岛素/能量信号
研究类别
代谢

Biochem/physiol Actions

该抗体识别人胰岛素受体β亚基的C末端。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

95kda
胰岛素受体是一种酪氨酸激酶受体,结合胰岛素时,启动多条信号转导通路,包括JNK、PI 3-激酶、Akt 和PKC。研究人员对于将这些胰岛素R依赖性通路的药物干预用于治疗胰岛素抵抗、肥胖和糖尿病有极大的兴趣。胰岛素受体(IR)被合成为单一多肽,该多肽随后裂解生成二硫键连接的一条胞外α链和一条跨膜胞内β链。β链具有多个酪氨酸磷酸化位点,包括激活环(activation loop)上的三个自磷酸化位点。IR 总体结构与IGF-I 受体高度同源,只是C末端的两个蛋白有些差异。 IR 信号主要通过胰岛素受体基质(IRS)蛋白质家族的磷酸化进行,该蛋白为含蛋白SHA结构域创造停泊位点(docking site)。胰岛素信号传导高度依赖于PI3 激酶通路和 Akt通路,Akt通路似乎介导胰岛素的功能。

Immunogen

对应于人胰岛素受体β亚基的C末端的重组蛋白。
表位:C端

Other Notes

浓度:请参考批次特异性浓缩物的检验报告。

Physical form

形式:纯化
纯化的小鼠单克隆IgG1κ溶于含0.1 M Tris-甘氨酸(pH 7.4),150 mM NaCl和0.05%叠氮化钠的缓冲液中。
蛋白G纯化

Preparation Note

自收到之日起,在2-8°C条件下可稳定保存1年。

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Marcello Casertano et al.
Pharmaceuticals (Basel, Switzerland), 15(3) (2022-03-27)
Diabetes mellitus (DM) represents a complex and multifactorial disease that causes metabolic disorders with acute and long-term serious complications. The onset of DM, with over 90% of cases of diabetes classified as type 2, implies several metabolic dysfunctions leading to
Massimo Genovese et al.
European journal of nutrition, 61(4), 1905-1918 (2022-01-24)
The impact of tea constituents on the insulin-signaling pathway as well as their antidiabetic activity are still debated questions. Previous studies suggested that some tea components act as Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors. However, their nature and mechanism of
Massimo Genovese et al.
Marine drugs, 19(10) (2021-10-23)
An in-depth study on the inhibitory mechanism on protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AR) enzymes, including analysis of the insulin signalling pathway, of phosphoeleganin, a marine-derived phosphorylated polyketide, was achieved. Phosphoeleganin was demonstrated to inhibit both enzymes
Rosaria Ottanà et al.
Molecules (Basel, Switzerland), 26(2) (2021-01-14)
Diabetes mellitus (DM) is a complex disease which currently affects more than 460 million people and is one of the leading cause of death worldwide. Its development implies numerous metabolic dysfunctions and the onset of hyperglycaemia-induced chronic complications. Multiple ligands
Junhee Park et al.
Nature communications, 13(1), 5594-5594 (2022-09-24)
Insulin receptor (IR) signaling defects cause a variety of metabolic diseases including diabetes. Moreover, inherited mutations of the IR cause severe insulin resistance, leading to early morbidity and mortality with limited therapeutic options. A previously reported selective IR agonist without

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持